1. Abrams, P, Cardozo, L, Fall, M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002; 187: 116–126.
Google Scholar | Crossref | Medline | ISI2. Gormley, EA, Lightner, DJ, Burgio, KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol 2012; 188(Suppl. 6): 2455–2463.
Google Scholar | Crossref | Medline | ISI3. Peters, KM, Carrico, DJ, Perez-Marrero, RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010; 183: 1438–1443.
Google Scholar | Crossref | Medline | ISI4. van der Pal, F, van Balken, MR, Heesakkers, JP, et al. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int 2006; 97: 547–550.
Google Scholar | Crossref | Medline5. Manríquez, V, Guzmán, R, Naser, M, et al. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol 2016; 196: 6–10.
Google Scholar | Crossref | Medline6. Martin-Garcia, M, Crampton, J. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in overactive bladder symptoms in women responders To Percutaneous Tibial Nerve Stimulation (PTNS). Physiotherapy 2019; 105: 469–475.
Google Scholar | Crossref | Medline7. Leroux, PA, Brassart, E, Lebdai, S, et al. Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder. World J Urol 2018; 36: 1455–1460.
Google Scholar | Crossref | Medline8. Ramírez-García, I, Blanco-Ratto, L, Kauffmann, S, et al. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: randomized control trial. Neurourol Urodyn 2019; 38: 261–268.
Google Scholar | Crossref | Medline9. Booth, J, Hagen, S, McClurg, D, et al. A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc 2013; 14: 270–274.
Google Scholar | Crossref | Medline10. Schreiner, L, dos Santos, TG, Knorst, MR, et al. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J 2010; 21: 1065–1070.
Google Scholar | Crossref | Medline11. Te Dorsthorst, MJ, Heesakkers, JPFA, van Balken, MR. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Neurourol Urodyn 2020; 39: 702–706.
Google Scholar | Crossref | Medline12. Sirls, ER, Killinger, KA, Boura, JA, et al. Percutaneous tibial nerve stimulation in the office setting: real-world experience of over 100 patients. Urology 2018; 113: 34–39.
Google Scholar | Crossref | Medline13. Peters, KM, Carrico, DJ, Wooldridge, LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol 2013; 189: 2194–2201.
Google Scholar | Crossref | Medline | ISI14. D’Souza, AO, Smith, MJ, Miller, LA, et al. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm 2008; 14: 291–301.
Google Scholar | Crossref | Medline15. MacDiarmid, S, Staskin, DR, Lucente, V, et al. Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence. J Urol 2019; 201: 967–972.
Google Scholar | Crossref | Medline16. Te Dorsthorst, MJ, Digesu, GA, Tailor, V, et al. 3-Year follow-up, of a new implantable tibial nerve stimulator for the treatment of Overactive Bladder Syndrome (OAB). J Urol 2020; 204: 545–550.
Google Scholar | Crossref | Medline17. Sievert, KD, Milinovic, L, Foditsch, E, et al. New novel chronic tibial neuromodulation (CTNM) treatment option for OAB significantly improves urgency (UI)/urge urinary incontinence (UUI) and normalizes sleep patterns: initial results. Eur Urol Suppl 2017; 16: e994.
Google Scholar | Crossref